No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract Obinutuzumab-atezolizumab-lenalidomide is effective and tolerable in patients with relapsed/refractory follicular lymphoma

byKathleen Lau

September 3, 2021

in StudyGraphics

More omega-3 and less omega-6 fatty acid consumption associated with reduced migraine frequency and severity

RelatedReports

Radiation plus hormone therapy may improve prostate cancer survival

Chronic Disease

Talazoparib and enzalutamide improve survival in metastatic castration-resistant prostate cancer

August 14, 2025

Rectal indomethacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients

Gastroenterology

mFOLFIRINOX may have a limited role in pancreatic cancer in Phase II/III trial

August 7, 2025

Severe subtype of acute lymphoblastic leukemia susceptible to FDA-approved kinase inhibitors

Chronic Disease

Overweight body habitus is associated with higher rates of relapse in children with acute lymphoblastic leukemia

August 7, 2025

Emergency

Neutrophil-to-lymphocyte ratio may be a useful marker of mortality in septic patients with liver cirrhosis

August 6, 2025

Quick Take: Amyotrophic Lateral Sclerosis versus Multifocal Motor Neuropathy: Utility of MR Neurography

Variants in the SPTLC1 gene associated with juvenile amyotrophic lateral sclerosis

Downward trend in mortality rate for antineutrophil cytoplasmic autoantibody-associated vasculitis

Eating disorder hospital admissions among adolescents increased during the COVID-19 pandemic

Women electing abortion more likely to be victims of domestic violence

2 Minute Medicine Rewind September 6, 2021

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports